Skip to main content
Contact Us
Sign Up
Subscriber Sign In
English
日本語
navigation
Search
COVID-19
COVID-19 Daily Update
COVID-19 EventAnalyzer
COVID-19 Stories from Evaluate Vantage
Evaluate’s Business Continuity Plan
What We Do
Commercial Intelligence
Products
EvaluatePharma
EvaluatePharma Vision
Japan Drug Forecasts
European Drug Forecasts
Epi Analyzer
Custom Solutions
Evaluate Vantage
News
Analysis
Policy & Pricing
Data Insights
Events
Medtech
Therapy Areas
Editorial Team
About Evaluate Vantage
How We Can Help You
Pharma and Biotech
Medtech
Financial Services
Management Consultancies
Service Providers
Customer Testimonials
Thought Leadership
English
日本語
About Us
Press Releases
Media Coverage
Executive Team
Vision & History
Careers
Current Vacancies
Contact Us
Sign Up for Vantage
Subscriber Sign In
Search
Open configuration options
Search
Vantage
News
Snippets
Deals
Trial results
Patents and litigation
Corporate strategy
Analysis
Interviews
Spotlight
Vantage points
Vantage views
Policy & Pricing
Policy & Regulation
Pricing
Data Insights
M&A
IPO
NME approvals
Quarterly shareprice performance
Venture financing
Vantage data points
Other data
Events
Company events
Conferences
Upcoming events
Medtech
Therapy Areas
About
Editorial team
Myriad Genetics
June 01, 2018
Snippet roundup: Fibrogen's Japanese hit and Madrigal's smash in Nash
March 16, 2018
Snippet roundup: J&J shrinks, while Vernalis vanishes altogether
November 03, 2017
GeneSight trial miss leaves Myriad depressed
January 09, 2017
A quiet year for mid-size medtech
December 20, 2016
Early visit from Santa puts the heat on Clovis
October 26, 2016
Lynparza shows that Parp competitors have it all to do
October 14, 2016
Snippet roundup: Biomarin boosted, Synairgen stung
October 12, 2016
Esmo event analyser – Tesaro tops the risers while Bristol-Myers is battered
October 09, 2016
Esmo – Tesaro enjoys a ta-dah moment
August 12, 2016
Snippet roundup: Lilly pill slips, Mek inhibitors reach limit, Myriad buys
August 24, 2015
Biomarin goes for pragmatism as the markets dip
Load More
We use cookies on this website. By using this site, you agree that we may store and access cookies on your device.
Find out more.
OK
Independent, data-driven daily news and analysis on pharma, biotech and medtech.
Sign up
Latest Reports
February 20, 2020
Evaluate Vantage Pharma, Biotech & Medtech 2019 in Review
December 17, 2019
Evaluate Vantage 2020 Preview
Editor's Picks
March 18, 2020
A Covid-19 treatment plan slowly emerges
March 11, 2020
Tiziana takes a deep breath and targets Covid-19
March 12, 2020
Estimating the cost of Covid-19 antiviral development
March 10, 2020
Few groups have developed Covid-19 diagnostics – but this will change
March 20, 2020
Clinical trial delays become reality as Covid-19 risk spreads
